Ilyang Pharmaceutical Co Ltd
KRX:007570
Ilyang Pharmaceutical Co Ltd
Income to Minority Interest
Ilyang Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
I
|
Ilyang Pharmaceutical Co Ltd
KRX:007570
|
Income to Minority Interest
-₩3.2B
|
CAGR 3-Years
35%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
Yuhan Corp
KRX:000100
|
Income to Minority Interest
₩4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Income to Minority Interest
₩2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Income to Minority Interest
-₩19.1B
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-11%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Income to Minority Interest
-₩6.5B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Ilyang Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
-3.2B
KRW
Based on the financial report for Mar 31, 2024, Ilyang Pharmaceutical Co Ltd's Income to Minority Interest amounts to -3.2B KRW.
What is Ilyang Pharmaceutical Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
18%
Over the last year, the Income to Minority Interest growth was 64%. The average annual Income to Minority Interest growth rates for Ilyang Pharmaceutical Co Ltd have been 35% over the past three years , 18% over the past five years .